Attached files

file filename
8-K - 8-K - SPARTON CORPspa-10022016x8xkearningsre.htm


 
 
Media Contact:
 
Joe McCormack
 
 
 
 
Sparton Corporation
 
 
 
 
Email: ir@sparton.com
 
 
 
 
Office: (847) 762-5800
FOR IMMEDIATE RELEASE
Sparton Corporation Reports Fiscal 2017 First Quarter Results
SCHAUMBURG, IL. - November 8, 2016 - Sparton Corporation (NYSE: SPA) today announced results for the first quarter of fiscal year 2017 ended October 2, 2016.
First Quarter Financial Results
• Net sales of $100.4 million
• Gross profit margin of 17.2%
• SG&A expenses of $13.4 million or 13.3% of sales; adjusted SG&A of $12.6 million, 12.6%
• Earnings per share of $0.01, adjusted EPS of $0.20
• Adjusted EBITDA of $6.1 million, a 6.1% adjusted EBITDA margin
• Borrowings under Credit Facility of $95.8 million
First Quarter Highlights
• 64 new program wins in the MDS Segment with expected annual revenue of $12.2 million when fully ramped up into production
• MDS has a trailing four quarter win revenue of $62 million, which continues to support our future organic growth.
• Backlog of:
$125 million in the MDS Segment
$119 million in the ECP Segment principally including:
$98 million in domestic sonobouys
$6 million in foreign sonobouys
$11 million in rugged displays
Joseph J. Hartnett, Interim President & CEO, commented, “First quarter revenues came in just above the midpoint of our guidance range. However, during the quarter we remained engaged in activities related to the exploration of a possible sale of the Company and we have not yet achieved the desired level of success in addressing operating performance issues, implementing cost saving initiatives or carrying out new business development activities. We anticipate that progress in these areas will accelerate upon the completion of the current sale process, whether from an agreement for a sale of the Company or from a determination that no such sale will occur.”
Joe McCormack, Senior Vice President and CFO, commented, “We continue to be focused on actively managing our working capital, driving free cash flow, and reducing our debt and leverage. Despite the costs associated with the exploration of a sale of the Company and increasing health care costs, we have been able to keep our overall SG&A expenses at a consistent run-rate through a continued focus on reducing our operating expenses throughout the Company.”
As previously announced, the Board of Directors of Sparton Corporation is exploring a possible sale of the Company. There can be no assurance that such a sale will occur.








SELECTED FINANCIAL DATA
 
For the Quarters Ended
 
Q1 FY17
 
Q1 FY16
 
(Dollars in thousands, except per share data)
Consolidated:
 
 
 
Net sales
$
100,367

 
$
106,691

Gross profit
17,285

 
21,138

Selling and administrative expenses
13,383

 
13,624

Operating income
1,332

 
4,498

Adjusted operating income (non-GAAP)
2,095

 
4,498

Earnings per share
0.01

 
0.24

Adjusted Earnings per share (non-GAAP)
0.20

 
0.41

EBITDA (non-GAAP)
5,071

 
8,261

Adjusted EBITDA (non-GAAP)
6,143

 
8,693

Adjusted EBITDA margin (non-GAAP)
6.1
%
 
8.1
%
Free cash flow (non-GAAP)
$
2,093

 
$
2,953

 
 
 
 
MDS Segment:
 
 
 
Gross sales
$
65,002

 
$
73,957

Intercompany sales
(2,200
)
 
(5,229
)
Net sales
62,802

 
68,728

Gross profit
7,294

 
10,296

Selling and administrative expenses
3,508

 
3,730

Allocation of corporate expenses
2,468

 
2,151

Operating Income (loss)
(514
)
 
2,341

Segment EBITDA, excluding corporate allocation (non-GAAP)
4,657

 
7,410

 
 
 
 
ECP Segment:
 
 
 
Gross sales
$
37,592

 
$
38,089

Intercompany sales
(27
)
 
(126
)
Net sales
37,565

 
37,963

Gross profit
9,991

 
10,842

Selling and administrative expenses
2,624

 
2,555

Allocation of corporate expenses
1,200

 
1,042

Operating Income
5,429

 
6,303

Segment EBITDA, excluding corporate allocation (non-GAAP)
7,228

 
7,982

Liquidity and Capital Resources
As of October 2, 2016, the Company had $78 million available under its $175 million credit facility.
Outlook
Mr. Hartnett concluded, “Looking forward, we expect fiscal year 2017 second quarter revenues to be in the range of $97 million to $101 million with a gross profit margin of approximately 18%.”
Conference Call
The Company will host a conference call on Wednesday, November 9, 2016 at 10:00 a.m. CST/11:00 a.m. EST to discuss its fiscal year 2017 first quarter financial results. To participate, callers should dial 800-743-4304. Participants should dial in at least 5 minutes prior to the start of the call. A web presentation link, including the slide presentation which will accompany the call, will also be available for the conference call: http://tinyurl.com/hwggh3m. The presentation and conference call audio will be available on Sparton’s website: http://www.sparton.com in the “Investors” section.





Non-GAAP Financial Measures
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (“GAAP”), Sparton Corporation has provided certain non-GAAP financial measures as additional information for its operating results. These measures have not been prepared in accordance with GAAP and may be different from measures used by other companies. Whenever we use non-GAAP financial measures, we designate these measures, which exclude the effects of certain expenses and income, as “adjusted” and provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. The non-GAAP financial measures eliminate or add certain items of expense and income from total operating expense and income taxes. Management believes that this presentation is helpful to investors in evaluating the current operational and financial performance of our business and facilitates comparisons to historical results of operations. Management discloses this information along with a reconciliation of the comparable GAAP amounts to provide access to the detail and nature of adjustments made to GAAP financial results. While some of these excluded items have been periodically reported in our statements of operations, their occurrence in future periods depends on future business and economic factors, among other evaluation criteria, and the occurrence of such events and factors may frequently be beyond the control of management.
When we calculate adjusted earnings per share, adjusted EBITDA and other adjustments to the statements of income, we exclude certain expenses and income because we believe that they are not related directly to the underlying performance of our fundamental business operations. We exclude these measures when reviewing financial results and for business planning. Although these events are reflected in our GAAP financial statements, these transactions may limit the comparability of our fundamental operations with prior and future periods. We believe EBITDA and adjusted EBITDA are commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. The Company does not intend, nor should the reader consider, EBITDA or adjusted EBITDA to be an alternative to operating income, net income, net cash provided by operating activities or any other items calculated in accordance with GAAP. The Company's definition of adjusted EBITDA may not be comparable with other companies. Accordingly, the measurement has limitations depending on its use.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 117th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has thirteen manufacturing locations and engineering design centers worldwide. Sparton's Web site may be accessed at www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10-K and Form 10-Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.










CONSOLIDATING FINANCIAL INFORMATION - Q1 FISCAL YEAR 2017
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
62,802

 
$
37,565

 
$
100,367

Cost of goods sold

 
55,508

 
27,574

 
83,082

Gross profit

 
7,294

 
9,991

 
$
17,285

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
7,251

 
3,508

 
2,624

 
13,383

Selling and administrative - Corp allocations
(3,668
)
 
2,468

 
1,200

 

Internal research and development

 

 
351

 
351

Amortization of intangible assets

 
1,832

 
387

 
2,219

Total operating expenses
3,583

 
7,808

 
4,562

 
15,953

Income (loss) from operations
(3,583
)
 
(514
)
 
5,429

 
1,332

Interest expense, net
(1,186
)
 
1

 

 
(1,185
)
Other income (expense)
(1
)
 
29

 
(8
)
 
20

Income taxes
(63
)
 

 
4

 
(59
)
Net income (loss)
$
(4,833
)
 
$
(484
)
 
$
5,425

 
$
108

Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
0.01

Diluted
 
 
 
 
 
 
0.01

Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,792,818

Diluted
 
 
 
 
 
 
9,792,818


CONSOLIDATING FINANCIAL INFORMATION - Q1 FISCAL YEAR 2016
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
68,728

 
$
37,963

 
$
106,691

Cost of goods sold

 
58,432

 
27,121

 
85,553

Gross profit

 
10,296

 
10,842

 
$
21,138

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
7,339

 
3,730

 
2,555

 
13,624

Selling and administrative - Corp allocations
(3,193
)
 
2,151

 
1,042

 

Internal research and development

 

 
513

 
513

Amortization of intangible assets

 
2,074

 
429

 
2,503

Total operating expenses
4,146

 
7,955

 
4,539

 
16,640

Income (loss) from operations
(4,146
)
 
2,341

 
6,303

 
4,498

Interest expense, net
(882
)
 
(1
)
 

 
(883
)
Other income (expense)
(8
)
 
103

 
(27
)
 
68

Income taxes
(1,289
)
 

 

 
(1,289
)
Net income (loss)
$
(6,325
)
 
$
2,443

 
$
6,276

 
$
2,394

Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
0.24

Diluted
 
 
 
 
 
 
0.24

Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,780,274

Diluted
 
 
 
 
 
 
9,780,274







CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

 
For First Quarter
 
2017
 
2016
 
($ in thousands)
Cash Flows from Operating Activities, net of
 
 
 
changes in working capital
$
4,279

 
$
6,305

Net changes in working capital
(1,067
)
 
(1,872
)
Cash Flows from Operating Activities
3,212

 
4,433

Cash Flows from Investing Activity:
 
 
 
Capital expenditures
(1,119
)
 
(1,480
)
Cash Flows from Investing Activity
(1,119
)
 
(1,480
)
Cash Flows from Financing Activities:
 
 
 
Net change in Credit Facility
(1,431
)
 
(15,700
)
Other financing activities
(76
)
 
20

Cash Flows from Financing Activities
(1,507
)
 
(15,680
)
Change in Cash and Cash Equivalents
586

 
(12,727
)
Cash and Cash Equivalents - Beginning
132

 
14,914

Cash and Cash Equivalents - Ending
$
718

 
$
2,187




CONDENSED CONSOLIDATED BALANCE SHEETS

 
October 2,
2016
 
July 3,
2016
 
($ in thousands)
Assets
 
 
 
Cash and cash equivalents
$
718

 
$
132

Accounts receivable, net
48,206

 
46,759

Inventories
67,771

 
77,871

Prepaid and other current assets
5,905

 
5,844

Property, plant and equipment, net
32,939

 
33,320

Goodwill
12,663

 
12,663

Other intangible assets, net
34,714

 
36,933

Other assets
31,894

 
32,476

Total assets
$
234,810

 
$
245,998

Liabilities and Shareholders’ Equity
 
 
 
Accounts payable
$
34,689

 
$
38,290

Accrued expenses
8,956

 
11,512

Other current liabilities
8,817

 
12,637

Credit facility
95,775

 
97,206

Capital lease obligations
369

 
332

Environmental
5,847

 
6,117

Pension
1,276

 
1,276

Shareholders’ Equity
79,081

 
78,628

Total Liabilities and Shareholders’ Equity
$
234,810

 
$
245,998






RECONCILIATION OF NON-GAAP MEASURES

EBITDA Reconciliation (Non-GAAP) - Q1 Fiscal Year 2017
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(4,833
)
 
$
(484
)
 
$
5,425

 
$
108

Interest expense, net
1,186

 
(1
)
 

 
1,185

Income taxes
63

 

 
(4
)
 
59

Amortization of intangible assets

 
1,832

 
387

 
2,219

Depreciation included in SG&A above
438

 
842

 
220

 
1,500

Selling and administrative - Corp allocations
(3,668
)
 
2,468

 
1,200

 

EBITDA, excluding corporate allocation
(6,814
)
 
4,657

 
7,228

 
5,071

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Costs related to potential sale of Company
629

 
34

 

 
663

Stock-based compensation
309

 

 

 
309

Other nonrecurring adjustments, net

 
100

 

 
100

Adjusted EBITDA, before corporate allocation
$
(5,876
)
 
$
4,791

 
$
7,228

 
$
6,143

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(2,208
)
 
$
2,323

 
$
6,028

 
$
6,143

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
6.1
%


EBITDA Reconciliation (Non-GAAP) - Q1 Fiscal Year 2016
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(6,325
)
 
$
2,443

 
$
6,276

 
$
2,394

Interest expense, net
882

 
1

 

 
883

Income taxes
1,289

 

 

 
1,289

Amortization of intangible assets

 
2,074

 
429

 
2,503

Depreciation included in SG&A above
216

 
741

 
235

 
1,192

Selling and administrative - Corp allocations
(3,193
)
 
2,151

 
1,042

 

EBITDA, excluding corporate allocation
(7,131
)
 
7,410

 
7,982

 
8,261

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Stock-based compensation
432

 

 

 
432

Adjusted EBITDA, before corporate allocation
$
(6,699
)
 
$
7,410

 
$
7,982

 
$
8,693

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(3,506
)
 
$
5,259

 
$
6,940

 
$
8,693

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
8.1
%








Adjusted SG&A and Operating Income (Non-GAAP)
 
For the Quarters Ended
 
Q1 FY17
 
Q1 FY16
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
(Dollars in thousands)
As reported
$
13,383

 
$
1,332

 
$
13,624

 
$
4,498

Percentage of sales
13.3
%
 
1.4
%
 
12.8
%
 
4.2
%
Costs related to potential sale of Company
663

 
663

 

 

Other nonrecurring adjustments
100

 
100

 

 

     Total adjustments
763

 
763

 

 

As adjusted
$
12,620

 
$
2,095

 
$
13,624

 
$
4,498

 
 
 
 
 
 
 
 
Adjusted percentage of sales
12.6
%
 
2.1
%
 
12.8
%
 
4.2
%




Adjusted EPS (Non-GAAP)
For the Quarters Ended
 
Q1 FY17
 
Q1 FY16
 
(Dollars in thousands, except per share data)
Earnings per share - diluted, as reported
$
0.01

 
$
0.24

Nonrecurring items
0.05

 

Amortization of intangible assets
0.14

 
0.17

Adjusted earnings per share
$
0.20

 
$
0.41

 
 
 
 
Adjustments, net of tax:
 
 
 
Costs related to potential sale of Company
$
431

 
$

Other nonrecurring adjustments
65

 

Total nonrecurring
496

 

Amortization of intangible assets
1,442

 
1,627

Total adjustments
$
1,938

 
$
1,627